Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0006 USD | 0.00% | 0.00% | -99.98% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
Quotes 5-day view
Delayed Quote Nasdaq2024-06-05 | 2024-06-06 | 2024-06-07 | 2024-06-10 | |
---|---|---|---|---|
Last | 0 $ | 0.0006 $ | 0.0006 $ | 0 $ |
Volume | 81 | 231 | 670 | 19 |
Change | -100.00% | +∞% | 0.00% | -100.00% |
Opening | 0.00 | 0.00 | 0.00 | 0.00 |
High | 0.00 | 0.00 | 0.00 | 0.00 |
Low | 0.00 | 0.00 | 0.00 | 0.00 |
Performance
Current month | -99.98% | ||
Current year | -99.98% | ||
3 years | -99.99% | ||
5 years | -99.96% | ||
10 years | -99.99% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | -99.98% | - | 43.55K | ||
-1.60% | +0.52% | +49.41% | +20.55% | 57.87B | ||
+0.16% | +3.34% | +41.65% | -10.98% | 40.25B | ||
-1.55% | -0.30% | -6.72% | +4.47% | 39.94B | ||
-0.84% | +5.87% | -5.96% | +12.13% | 28.54B | ||
+0.18% | -1.13% | +12.99% | +44.12% | 26.4B | ||
+0.45% | +2.01% | -19.82% | -19.58% | 19.33B | ||
+1.12% | +4.18% | +32.35% | +95.17% | 12.4B | ||
-0.68% | -1.03% | -0.08% | -1.70% | 12.23B | ||
+0.09% | -0.37% | +25.18% | +20.46% | 12.2B | ||
-0.13% | +3.16% | -9.26% | +8.51% | 11.06B | ||
+0.07% | +2.00% | +0.24% | -3.88% | 9.95B | ||
-1.19% | -0.77% | +38.98% | +56.07% | 6.66B | ||
0.00% | +0.64% | +20.69% | -10.95% | 6.56B | ||
+0.67% | -0.77% | +12.78% | +77.92% | 6.47B | ||
+0.25% | +6.44% | +3.78% | -20.25% | 6.35B | ||
Average | -0.09% | +1.31% | +6.01% | +18.14% | ||
Weighted average by Cap. | -0.22% | +1.38% | +17.44% | +14.18% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2021 | -5.22% | ||
2020 | +473.09% | ||
2019 | -40.40% | ||
2018 | -74.81% | ||
2017 | +182.39% | ||
2016 | -59.31% | ||
2015 | -38.77% | ||
2014 | -75.64% | ||
2013 | -12.03% | ||
2012 | -53.50% | ||
2011 | -60.39% | ||
2010 | +118.13% | ||
2009 | +55.40% | ||
2008 | -75.80% | ||
2007 | +74.60% | ||
2006 | -6.67% |
- Stock Market
- Equities
- STAB Stock
- STAB Stock
- Quotes Statera Biopharma, Inc.